TSHZ3
Basic information
Region (hg38): 19:31149979-31349436
Previous symbols: [ "ZNF537" ]
Links
Phenotypes
GenCC
Source:
- congenital anomaly of kidney and urinary tract (Limited), mode of inheritance: AD
- autism spectrum disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TSHZ3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 19 | 23 | ||||
missense | 58 | 64 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 59 | 24 | 5 |
Variants in TSHZ3
This is a list of pathogenic ClinVar variants found in the TSHZ3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-31276559-T-A | not specified | Uncertain significance (Jan 23, 2024) | ||
19-31276590-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
19-31276601-G-A | TSHZ3-related disorder | Likely benign (Nov 07, 2019) | ||
19-31276648-T-A | not specified | Uncertain significance (Feb 02, 2024) | ||
19-31276649-C-T | TSHZ3-related disorder | Likely benign (Jun 24, 2019) | ||
19-31276759-C-T | not specified | Uncertain significance (Jun 22, 2021) | ||
19-31276773-G-C | not specified | Uncertain significance (Sep 06, 2022) | ||
19-31276782-C-T | not specified | Uncertain significance (May 27, 2022) | ||
19-31276852-A-C | not specified | Uncertain significance (May 09, 2023) | ||
19-31276870-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
19-31276958-G-A | Likely benign (Dec 01, 2022) | |||
19-31276966-T-G | not specified | Uncertain significance (Oct 26, 2021) | ||
19-31276975-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
19-31277139-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
19-31277148-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
19-31277152-C-T | TSHZ3-related disorder | Uncertain significance (Mar 26, 2024) | ||
19-31277167-C-T | not specified | Uncertain significance (Mar 23, 2022) | ||
19-31277191-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
19-31277216-C-T | TSHZ3-related disorder | Likely benign (Feb 01, 2023) | ||
19-31277280-G-A | not specified | Uncertain significance (Jun 10, 2022) | ||
19-31277291-C-T | not specified | Uncertain significance (Sep 22, 2023) | ||
19-31277302-C-A | not specified | Uncertain significance (Oct 04, 2022) | ||
19-31277305-C-T | not specified | Uncertain significance (Jan 07, 2022) | ||
19-31277331-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
19-31277332-T-C | not specified | Uncertain significance (Jan 22, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TSHZ3 | protein_coding | protein_coding | ENST00000240587 | 2 | 74603 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.991 | 0.00947 | 125744 | 0 | 4 | 125748 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.83 | 519 | 651 | 0.798 | 0.0000408 | 7131 |
Missense in Polyphen | 165 | 266.96 | 0.61806 | 3070 | ||
Synonymous | -0.968 | 320 | 299 | 1.07 | 0.0000224 | 2142 |
Loss of Function | 4.30 | 3 | 27.2 | 0.110 | 0.00000132 | 371 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000619 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000177 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional regulator involved in developmental processes. Function in association with APBB1, SET and HDAC factors as a transcriptional repressor, that inhibits the expression of CASP4. TSHZ3-mediated transcription repression involves the recruitment of histone deacetylases HDAC1 and HDAC2. Associates with chromatin in a region surrounding the CASP4 transcriptional start site(s) (PubMed:19343227). Regulates the development of neurons involved in both respiratory rhythm and airflow control. Promotes maintenance of nucleus ambiguus (nA) motoneurons, which govern upper airway function, and establishes a respiratory rhythm generator (RRG) activity compatible with survival at birth. Involved in the differentiation of the proximal uretic smooth muscle cells during developmental processes. Involved in the up-regulation of myocardin, that directs the expression of smooth muscle cells in the proximal ureter (By similarity). Involved in the modulation of glutamatergic synaptic transmission and long-term synaptic potentiation (By similarity). {ECO:0000250|UniProtKB:Q8CGV9, ECO:0000269|PubMed:19343227}.;
- Disease
- DISEASE: Note=TSHZ3 haploinsufficiency due to proximal chromosome 19q13.11 deletions causes a neurodevelopmental disorder characterized by developmental delay, absent or delayed speech, intellectual disability, and autistic features. Some patients may have reanal tract abnormalities. {ECO:0000269|PubMed:27668656}.;
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- 0.135
- rvis_EVS
- -1.72
- rvis_percentile_EVS
- 2.49
Haploinsufficiency Scores
- pHI
- 0.866
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.574
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.762
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tshz3
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; renal/urinary system phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of respiratory gaseous exchange by neurological system process;regulation of transcription by RNA polymerase II;multicellular organism development;negative regulation of transcription, DNA-templated;positive regulation of synaptic transmission, glutamatergic;long-term synaptic potentiation
- Cellular component
- nucleus;nucleoplasm;growth cone
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;chromatin binding;protein binding;metal ion binding